Search
Search Constraints
You searched for: Author/Creator Laengle, JohannesLimit your search
- Laengle, Johannes [remove] 6
- Electronic journals 2
- 570 1
- 572.579 1
- 616.362005 1
- 616.994 1
- 616.994059005 1
- 616.99406105 1
- AVC ampulla of Vater cancer -- AC anal cancer -- ALK anaplastic lymphoma kinase -- APC antigen presenting cell -- BATF3 basic leucine zipper transcription factor ATF-like 3 -- BTC biliary tract cancer -- CALR calreticulin -- CAPOX capecitabine, oxaliplatin -- CB carboplatin -- CRT chemoradiotherapy -- ChT chemotherapy -- CD cluster of differentiation -- CC colon cancer -- CRC colorectal cancer -- CLM colorectal liver metastases -- CPS combined positive score -- COX-2 cyclooxygenase-2 -- CTLA-4 cytotoxic T-lymphocyte-associated protein 4 -- DAMPs damage-associated molecular patterns -- DCs dendritic cells -- DFS disease-free survival -- dCCA distal cholangiocarcinoma -- DOC docetaxel, oxaliplatin, capecitabine -- AC doxorubicin, cyclophosphamide -- EGFR epidermal growth factor receptor -- EAC esophageal adenocarcinoma -- EC esophageal cancer -- ESCC esophageal squamous-cell carcinoma -- EFS event-free survival -- eCCA extrahepatic cholangiocarcinoma -- 5-FU fluorouracil -- FLOT fluorouracil, docetaxel, oxaliplatin, leucovorin -- FOLFIRINOX folinic acid, fluorouracil, irinotecan, oxaliplatin -- FOLFOX4 folinic acid, fluorouracil, oxaliplatin 4 -- GBM Glioblastoma -- FDA food and drug administration -- GEJ gastroesophageal junction -- GI gastrointestinal -- GI NET gastrointestinal neuroendocrine tumor -- GIST gastrointestinal stromal tumors -- GEMOX gemcitabine, oxaliplatin -- cGAS GMP-AMP synthase -- GM-CSF granulocyte-macrophage colony-stimulating factor -- Gy gray -- HNSCC head and neck squamous cell carcinoma -- HSP heat shock proteins -- HCC hepatocellular carcinoma -- HSV herpes simplex viruses -- HMGB1 high-mobility-group-protein b1 -- HPV human papillomavirus -- ICI immune checkpoint inhibitors -- irAEs immune-related adverse events -- ICD immunogenic cell death -- IDO indoleamine-pyrrole 2, 3-dioxygenase -- IAV influenza A virus -- IMRT intensity modulated radiotherapy -- ITT intention-to-treat -- IFN interferon -- IL interleukin -- INMC international neoadjuvant melanoma consortium -- iCCA intrahepatic cholangiocarcinoma -- i.p. intraperitoneal -- i.v. intravenously -- LARC locally advanced rectal cancer -- LN lymph node -- LAG-3 lymphocyte-activation gene 3, MPR: major pathological response -- MV measles virus -- MSI microsatellite instable -- MSS microsatellite stable -- MIS minimally invasive surgery -- MoA mode of action -- mFOLFOX6 modified folinic acid, fluorouracil, oxaliplatin 6 -- MSI-L MSI-Low -- MKI multikinase-inhibitor -- MIBC muscle invasive bladder cancer -- MG myasthenia gravis -- NK natural killer cell -- NDV newcastle-disease-virus -- NMIBC non-muscle-invasive bladder cancer -- NSCLC non-small cell lung cancer -- OV oncolytic viruses -- OS overall survival -- PTX paclitaxel -- PDAC pancreatic ductal adenocarcinoma -- pCR pathological complete response -- pCCA/Klatskin perihilar cholangiocarcinoma -- POT perioperative treatment -- PD-L1 programmed cell death 1 ligand 1 -- PD-1 programmed cell death protein 1 -- PFS progression-free survival -- RT radiotherapy -- RWD real world data -- RC rectal cancer -- RFS relapse-free survival -- SASP senescence-associated secretory phenotype -- SCPRT short-course pre-operative radiotherapy -- SIRPα signal regulatory protein α -- S1P sphingosine-1-phosphate receptor modulator -- SOC standard of care -- SBRT stereotactic body radiation therapy -- STING stimulator of interferon genes -- s.c. subcutaneous -- TIM-3 T cell immunoglobulin and mucin-domain containing-3 -- Th17 T helper 17 cell -- Treg T regulatory cell -- TREX1 three prime repair exonuclease 1 -- TLR4 toll-like receptor 4 -- TNT total neoadjuvant therapy -- TACE transcatheter arterial chemoembolization -- TNBC triple negative breast cancer -- TIME tumor immune microenvironment -- TMB tumor mutational burden -- TAAs tumor-associated antigens -- TAM tumor-associated macrophage -- VV vaccina virus -- VEGF-A vascular endothelial growth factor A -- vs versus -- VSV vesicular stomatitis virus -- W&W watch and wait 1
- Biliary tract -- Diseases -- Periodicals 1
- Biochemistry -- Periodicals 1